Inventor
VAN WAGENEN BRADFORD C
US20 patents
⚠️ This page may combine multiple inventors who share the name “VAN WAGENEN BRADFORD C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NPS PHARMA INC
17 patentsUS6211244B1Apr 3, 2001
Calcium receptor-active compounds
NPS PHARMA INC251 citations98
US6031003AFeb 29, 2000
Calcium receptor-active molecules
NPS PHARMA INC151 citations98
US6313146B1Nov 6, 2001
Calcium receptor-active molecules
NPS PHARMA INC104 citations97
US6001884ADec 14, 1999
Calcium receptor-active molecules
NPS PHARMA INC100 citations97
US6022894AFeb 8, 2000
Method of using calcilytic compounds
NPS PHARMA INC51 citations95
US5981599ANov 9, 1999
Inorganic ion receptor active compounds
NPS PHARMA INC70 citations95
US6429207B1Aug 6, 2002
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
NPS PHARMA INC67 citations92
US6342532B1Jan 29, 2002
Inorganic ion receptor active compounds
NPS PHARMA INC22 citations92
US6521667B1Feb 18, 2003
Calcilytic compounds
NPS PHARMA INC28 citations91
US6432656B1Aug 13, 2002
Calcilytic compounds
NPS PHARMA INC41 citations91
US7202261B2Apr 10, 2007
Calcilytic compounds
NPS PHARMA INC13 citations83
US6818660B2Nov 16, 2004
Calcilytic compounds
NPS PHARMA INC14 citations83
US5506268AApr 9, 1996
Use of isovaleramide as a mild anxiolytic and sedative agent
NPS PHARMA INC15 citations82
US6710088B2Mar 23, 2004
Inorganic ion receptor-active compounds
NPS PHARMA INC8 citations73
US6051610AApr 18, 2000
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
NPS PHARMA INC8 citations73
US7053104B2May 30, 2006
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
NPS PHARMA INC9 citations71
US5763494AJun 9, 1998
Pharmaceutical compositions comprising isovaleramide
NPS PHARMA INC4 citations63